In contrast to our hypothesis, inhibition of NHE‐1 with KR32568 provided further protection from ischemic stroke, and the beneficial effects of both pre‐ and post‐treatment with KR32568 were similar in WT and Hv1−/− rats. This evidence concerns the gene SLC9A1 and ischemic stroke.